Found: 6
Select item for more details and to access through your institution.
Altered dopamine release and monoamine transporters in Vps35 p.D620N knock-in mice.
- Published in:
- NPJ Parkinson's Disease, 2018, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41531-018-0063-3
- By:
- Publication type:
- Article
LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory.
- Published in:
- Human Molecular Genetics, 2015, v. 24, n. 5, p. 1336, doi. 10.1093/hmg/ddu543
- By:
- Publication type:
- Article
DNAJC13 mutations in Parkinson disease.
- Published in:
- Human Molecular Genetics, 2014, v. 23, n. 7, p. 1794
- By:
- Publication type:
- Article
Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in mice.
- Published in:
- eLife, 2017, p. 1, doi. 10.7554/eLife.28377
- By:
- Publication type:
- Article
Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice.
- Published in:
- Frontiers in Cellular Neuroscience, 2014, v. 8, p. 1, doi. 10.3389/fncel.2014.00301
- By:
- Publication type:
- Article
Inhibition of LRRK2 kinase activity rescues deficits in striatal dopamine physiology in VPS35 p.D620N knock-in mice.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00609-7
- By:
- Publication type:
- Article